Since quiescence can protect cancer cells from chemotherapy agents that target cycling cells, we wanted to see if loss of p21-dependent quiescence in TP53WT NSCLC cells would sensitise them to chemotherapy. This evidence concerns the gene CDKN1A and non-small cell lung carcinoma.